Molecular docking predicted interactions between gut microbiota metabolites and the key target.<h4>Results</h4>We identified 34 gut microbiota-related DEGs, which were enriched in pathways like inflammatory bowel disease and IL-17 signaling. The gene discussed is IL17A; the disease is inflammatory bowel disease.